Literature DB >> 20065112

Costimulator B7-DC attenuates strong Th2 responses induced by Nippostrongylus brasiliensis.

Kenji Ishiwata1, Naohiro Watanabe, Miao Guo, Kei Tomihara, Michael J Brumlik, Hideo Yagita, Drew Pardoll, Lieping Chen, Tahiro Shin.   

Abstract

The caliber and magnitude of T cell responses are regulated by costimulatory molecules following the engagement of TCRs and MHC molecules. B7-DC has the highest homology with B7-H1 in the B7 family, and both of them bind an immunoregulatory molecule, programmed death 1. Previous studies have demonstrated that B7-DC stimulates T cell proliferation and CTL generation, which sharply contrasts the inhibitory role of B7-H1. Th2 cytokines prompt B7-DC expression, which in turn enhances Th1 responses. In this study, we used an intestinal nematode, Nippostrongylus brasiliensis, to induce strong Th2 responses and to evaluate B7-DC function under Th2-polarizing conditions in vivo. By either blocking B7-DC expression during N. brasiliensis infection or by examining N. brasiliensis-infected B7-DC knockout mice, we observed enhanced eosinophilia, the overproduction of serum IgE, and increased Th2 cytokine production along with decreased Th1 cytokine production (particularly IFN-gamma production), indicating that B7-DC inhibits Th2 responses. Our results further demonstrate that the inhibition of Th2 responses by B7-DC occurs independently of programmed death 1 but conceivably acts through an as yet unknown alternative receptor that enhances Th1 responses. Although the deficiency of B7-DC expression that enhanced the production of IL-13 paradoxically resulted in better protection against N. brasiliensis infection, our results show that B7-DC plays an important role in bolstering a robust Th1 response that is required for effective antiviral and anticancer immunity, even under a strong Th2-polarizing environment induced by N. brasiliensis infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065112      PMCID: PMC4862405          DOI: 10.4049/jimmunol.0804051

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.

Authors:  P'ng Loke; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  B7-DC induced by IL-13 works as a feedback regulator in the effector phase of allergic asthma.

Authors:  Koichiro Matsumoto; Satoru Fukuyama; Miyuki Eguchi-Tsuda; Takako Nakano; Takafumi Matsumoto; Mikiko Matsumura; Atsushi Moriwaki; Keiko Kan-o; Yoshihiro Wada; Hideo Yagita; Tahiro Shin; Drew M Pardoll; Rirprajak Patcharee; Miyuki Azuma; Yoichi Nakanishi; Hiromasa Inoue
Journal:  Biochem Biophys Res Commun       Date:  2007-11-05       Impact factor: 3.575

Review 4.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

5.  Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism.

Authors:  Bruce R Blazar; Beatriz M Carreno; Angela Panoskaltsis-Mortari; Laura Carter; Yoshiko Iwai; Hideo Yagita; Hiroyuki Nishimura; Patricia A Taylor
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 6.  Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites.

Authors:  Fred D Finkelman; Terez Shea-Donohue; Suzanne C Morris; Lucy Gildea; Richard Strait; Kathleen B Madden; Lisa Schopf; Joseph F Urban
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

7.  T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.

Authors:  M Yamashita; M Katsumata; M Iwashima; M Kimura; C Shimizu; T Kamata; T Shin; N Seki; S Suzuki; M Taniguchi; T Nakayama
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

8.  Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.

Authors:  J Cui; N Watanabe; T Kawano; M Yamashita; T Kamata; C Shimizu; M Kimura; E Shimizu; J Koike; H Koseki; Y Tanaka; M Taniguchi; T Nakayama
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

9.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

10.  B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

Authors:  Xingluo Liu; Jian Xin Gao; Jing Wen; Lijie Yin; Ou Li; Tao Zuo; Thomas F Gajewski; Yang-Xin Fu; Pan Zheng; Yang Liu
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more
  18 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

Review 2.  PD-1/PD-L1 inhibitors.

Authors:  Joel Sunshine; Janis M Taube
Journal:  Curr Opin Pharmacol       Date:  2015-06-02       Impact factor: 5.547

Review 3.  Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion.

Authors:  Victor E Reyes; Alex G Peniche
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

4.  Aging-associated B7-DC+ B cells enhance anti-tumor immunity via Th1 and Th17 induction.

Authors:  Kei Tomihara; Takako Shin; Vincent J Hurez; Hideo Yagita; Drew M Pardoll; Bin Zhang; Tyler J Curiel; Tahiro Shin
Journal:  Aging Cell       Date:  2011-11-28       Impact factor: 9.304

5.  CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity.

Authors:  Yosuke Kumamoto; Melissa Linehan; Jason S Weinstein; Brian J Laidlaw; Joseph E Craft; Akiko Iwasaki
Journal:  Immunity       Date:  2013-09-26       Impact factor: 31.745

6.  Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells.

Authors:  Yan Gao; Simone A Nish; Ruoyi Jiang; Lin Hou; Paula Licona-Limón; Jason S Weinstein; Hongyu Zhao; Ruslan Medzhitov
Journal:  Immunity       Date:  2013-09-26       Impact factor: 31.745

7.  Programmed death ligand 2 regulates arginase induction and modifies Trypanosoma cruzi survival in macrophages during murine experimental infection.

Authors:  Laura R Dulgerian; Vanina V Garrido; Cinthia C Stempin; Fabio M Cerbán
Journal:  Immunology       Date:  2011-02-08       Impact factor: 7.397

8.  Fusion protein of mutant B7-DC and Fc enhances the antitumor immune effect of GM-CSF-secreting whole-cell vaccine.

Authors:  Masatsugu Kojima; Satoshi Murata; Eiji Mekata; Katsushi Takebayashi; Elizabeth M Jaffee; Tohru Tani
Journal:  J Immunother       Date:  2014-04       Impact factor: 4.456

9.  Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer.

Authors:  Mario Sznol; Lieping Chen
Journal:  Clin Cancer Res       Date:  2013-03-01       Impact factor: 12.531

10.  PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.

Authors:  Jerome T McKay; Marcela A Haro; Christina A Daly; Rama D Yammani; Bing Pang; W Edward Swords; Karen M Haas
Journal:  J Immunol       Date:  2017-08-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.